1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
- -------------------------------------------------------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): March 1, 2001
AMEDISYS, INC.
--------------
(Exact Name of Registrant as Specified in Charter)
Delaware
--------
(State or Other Jurisdiction of
Incorporation or Organization)
0-24260 11-3131700
-------- ----------
(Commission File Number) (I.R.S. Employer Identification No.
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
-------------------------------------------------
(Address of principal executive offices including zip code)
(225) 292-2031
--------------
(Registrant's telephone number, including area code)
2
ITEM 5. OTHER EVENTS
On March 1, 2001, Amedisys, Inc., "the Company"
issued a press release attached hereto as Exhibit 99.1 to
announce quarter and year ended December 31, 2000 operating
results.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibit
No.
Page
----
99.1(i) Press Release dated March 1, 2001
announcing quarter and year ended December 31,
2000 operating results........................... A-1
(i) Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By: /s/ John M. Joffrion
---------------------------------------
John M. Joffrion
Senior Vice President of Finance
Principal Accounting and Financial Officer
DATE: March 1, 2001
3
INDEX TO EXHIBITS
Exhibit
No. Description
- ------- -----------
99.1(i) Press Release dated March 1, 2001 announcing quarter and year
ended December 31, 2000 operating results
(i) Filed herewith.